G1 Therapeutics Inc (GTHX) is around the top of the Biotechnology industry according to InvestorsObserver. GTHX received an overall rating of 55, which means that it scores higher than 55 percent of all stocks. G1 Therapeutics Inc also achieved a score of 90 in the Biotechnology industry, putting it above 90 percent of Biotechnology stocks. Biotechnology is ranked 109 out of the 148 industries.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 55 means the stock is more attractive than 55 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With G1 Therapeutics Inc Stock Today?
G1 Therapeutics Inc (GTHX) stock has gained 3.42% while the S&P 500 is down -0.27% as of 2:01 PM on Monday, Jun 14. GTHX has risen $0.74 from the previous closing price of $21.62 on volume of 544,976 shares. Over the past year the S&P 500 has gained 38.13% while GTHX has risen 14.31%. GTHX lost -$2.45 per share the over the last 12 months.
Click Here to get the full Stock Score Report on G1 Therapeutics Inc (GTHX) Stock.
